Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash & Current Investments: 2022-2024

Historic Cash & Current Investments for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $294.5 million.

  • Gossamer Bio's Cash & Current Investments fell 44.89% to $180.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $945.6 million, marking a year-over-year decrease of 22.64%. This contributed to the annual value of $294.5 million for FY2024, which is 0.64% down from last year.
  • As of FY2024, Gossamer Bio's Cash & Current Investments stood at $294.5 million, which was down 0.64% from $296.4 million recorded in FY2023.
  • Over the past 5 years, Gossamer Bio's Cash & Current Investments peaked at $296.4 million during FY2023, and registered a low of $255.7 million during FY2022.
  • For the 3-year period, Gossamer Bio's Cash & Current Investments averaged around $282.2 million, with its median value being $294.5 million (2024).
  • In the last 5 years, Gossamer Bio's Cash & Current Investments grew by 15.94% in 2023 and then dropped by 0.64% in 2024.
  • Over the past 3 years, Gossamer Bio's Cash & Current Investments (Yearly) stood at $255.7 million in 2022, then grew by 15.94% to $296.4 million in 2023, then decreased by 0.64% to $294.5 million in 2024.